Correlation Between Biodexa Pharmaceticals and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and Spero Therapeutics, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Spero Therapeutics.
Diversification Opportunities for Biodexa Pharmaceticals and Spero Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biodexa and Spero is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Biodexa Pharmaceticals and Spero Therapeutics
Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to under-perform the Spero Therapeutics. In addition to that, Biodexa Pharmaceticals is 2.2 times more volatile than Spero Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Spero Therapeutics is currently generating about -0.14 per unit of volatility. If you would invest 129.00 in Spero Therapeutics on August 27, 2024 and sell it today you would lose (13.00) from holding Spero Therapeutics or give up 10.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biodexa Pharmaceticals vs. Spero Therapeutics
Performance |
| Timeline |
| Biodexa Pharmaceticals |
| Spero Therapeutics |
Biodexa Pharmaceticals and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biodexa Pharmaceticals and Spero Therapeutics
The main advantage of trading using opposite Biodexa Pharmaceticals and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Biodexa Pharmaceticals vs. Doubledown Interactive Co | Biodexa Pharmaceticals vs. Verde Clean Fuels | Biodexa Pharmaceticals vs. China Clean Energy | Biodexa Pharmaceticals vs. Ultra Clean Holdings |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |